Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Lin, NU; Diéras, V; Paul, D; Lossignol, D; Christodoulou, C; Stemmler, HJ; Roché, H; Liu, MC; Greil, R; Ciruelos, E; Loibl, S; Gori, S; Wardley, A; Yardley, D; Brufsky, A; Blum, JL; Rubin, SD; Dharan, B; Steplewski, K; Zembryki, D; Oliva, C; Roychowdhury, D; Paoletti, P; Winer, EP; CLIN CANCER RES. 2009; 15(4): 1452-1459.

Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.

Tinhofer, I; Weiss, L; Gassner, F; Rubenzer, G; Holler, C; Greil, R; J Immunother. 2009; 32(3):302-309

PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.

Holler, C; Piñón, JD; Denk, U; Heyder, C; Hofbauer, S; Greil, R; Egle, A; Blood. 2009; 113(12):2791-2794

Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

Engert, A; Borchmann, P; Pluetschow, A; von Tresckow, B; Markova, J; Hitz, F; Kral, Z; Greil, R; Topp, MS; Villalobos, M; Zijlstra, JM; Soekler, M; Stein, H; Eich, HT; Mueller, RP; Fuchs, M; Diehl, V BLOOD. 2010; 116(21): 336-336.

Deletion of Puma and p21(Waf1) In Mice Deactivates p53-Induced Cell Death and Cell Cycle Arrest, but Protects Mice From Irradiation-Induced Lymphomagenesis by a Mechanism Involving Hemopoietic Stem Cell Quiescence

Hofbauer, JP; Holler, C; Denk, U; Asslaber, D; Fastner, G; Labi, V; Villunger, A; Greil, R; Egle, A BLOOD. 2010; 116(21): 45-46.

VLA-4 and CD38 in chronic lymphocytic leukemia – more than prognostic markers?

Brechtl, G; Denk, U; Pinon-Hofbauer, JD; Greil, R; Hartmann, TN ONKOLOGIE. 2010; 33: 201-202.

Enzastaurin kills human CLL cells regardless of clinical risk profile, but fails to prolong life in a murine CLL model

Kocher, T; Pinon, HJ; Holler, C; Denk, U; Greil, R; Egle, A ONKOLOGIE. 2010; 33: 40-40.

The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells

Sahakyan, K; Hofbauer, S; Brachtl, G; Girbl, T; Henschler, R; Greil, R; Hartmann, TN ONKOLOGIE. 2010; 33: 201-201.

ABCSG-24: EFFICACY OF ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT THERAPY +/- CAPECITABINE (C) IN TRIPLE-NEGATIVE EARLY BREAST CANCER (TNBC)

Steger, GG; Greil, R; Jakesz, R; Mlineritsch, B; Lang, A; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M ANN ONCOL. 2010; 21: 79-79.

ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12

Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Poestlberger, S; Steger, GG; Jakesz, R; Singer, CF; Eidtmann, H; Greil, R ANN ONCOL. 2010; 21: 79-79.